Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Corcept Therapeutics Inc patents


Recent patent applications related to Corcept Therapeutics Inc. Corcept Therapeutics Inc is listed as an Agent/Assignee. Note: Corcept Therapeutics Inc may have other listings under different names/spellings. We're not affiliated with Corcept Therapeutics Inc, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "C" | Corcept Therapeutics Inc-related inventors


Optimizing mifepristone levels for cushing's patients

The present invention provides a method for optimizing levels of mifepristone in a patient suffering from cushing's syndrome. The method comprises the steps of treating the patient with seven or more daily doses of mifepristone over a period of seven or more days; testing the serum levels of the patient to determine whether the blood levels of mifepristone are greater than 1631 ng/ml; and adjusting the daily dose of the patient to achieve mifepristone blood levels greater than 1631 ng/ml.. ... Corcept Therapeutics Inc

Use of glucocorticoid receptor antagonist and somatostatin analogues to treat acth-secreting tumors

. . Methods, compositions, and pharmaceutical formulations are provided for treatment of acth secreting tumors.. . ... Corcept Therapeutics Inc

Methods for treating and diagnosing cushing's syndrome

Methods are provided for assessing a clinical response to a glucocorticoid receptor antagonist (gra) in a human subject and for diagnosing cushing's syndrome.. . ... Corcept Therapeutics Inc

Use of glucocorticoid receptor antagonists in combination with glucocorticoids to treat adrenal insufficiency

This invention provides for a method of treating secondary adrenal insufficiency by co-administrating therapeutically effective amounts of a glucocorticoid and a glucocorticoid receptor antagonist to the patient in need thereof. In some embodiments, the method includes the proviso that the patient not be otherwise in need of treatment with a glucocorticoid and a glucocorticoid receptor antagonist. ... Corcept Therapeutics Inc

Method for differentially diagnosing acth-dependent cushing's syndrome

. . This invention provides for an improved method for differentially diagnosing acth-dependent cushing's syndrome. Current practice for differentially diagnosing ectopic acth syndrome and cushing's disease measures relative acth concentrations from the inferior petrosal venous sinus compared to fluid obtained from a periphery venous sample. ... Corcept Therapeutics Inc

Differential diagnosis of ectopic cushing's syndrome

Improved methods and systems for diagnosing and for treating cushing's syndrome and cushing's disease are provided herein, including methods and systems for concurrently treating cushing's syndrome and differentially diagnosing cushing's disease from ectopic cushing's syndrome in a patient with an established diagnosis of acth-dependent cushing's syndrome. Treatment methods can use glucocorticoid receptor antagonists (gras), which differentially affect the ratio of cortisol to acth levels in patients having cushing's disease versus patients having ectopic cushing's syndrome. ... Corcept Therapeutics Inc

Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators

. . . . The present invention provides heteroaryl ketone fused azadecalin compounds and methods of using the compounds as glucocorticoid receptor modulators.. . ... Corcept Therapeutics Inc

Method for differentially diagnosing acth-dependent cushing's syndrome

This invention provides for an improved method for differentially diagnosing acth-dependent cushing's syndrome. Current practice for differentially diagnosing ectopic acth syndrome and cushing's disease measures relative acth concentrations from the inferior petrosal venous sinus compared to fluid obtained from a periphery venous sample. ... Corcept Therapeutics Inc

Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators

The present invention provides heteroaryl ketone fused azadecalin compounds and methods of using the compounds as glucocorticoid receptor modulators.. . ... Corcept Therapeutics Inc








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Corcept Therapeutics Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Corcept Therapeutics Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###